[ET Net News Agency, 18 January 2022] BRII-B (02137) rose 9.13% to HK$24.5.
It hits an intra-day high of HK$24.7, and an intra-day low of HK$22.55. The total shares
traded was 2 million, with a value of HK$47.63m. The active buy/sell ratio is 59:41, with
net buying turnover of HK$8.42m. INTERACTIVE BRO (HK) accounts for greatest net responsive
buying turnover of HK$1.93m, with volume weighted average price of HK$23.597. MERRILL
LYNCH FE accounts for greatest net responsive selling turnover of HK$5.09m, with volume
weighted average price of HK$23.782. The stock has risen a combined 10.86% over the past 2
consecutive trading days.
The Hang Seng Index now rose 126 points, or 0.52% to 24,344; the Hang Seng China
Enterprises Index now rose 79 points, or 0.94% to 8,543; the Hang Seng TECH Index now rose
104 points, or 1.82% to 5,828; with an overall turnover of HK$24.12b.
The SSE Composite Index now rose 14 points, or 0.4% to 3,555, with an overall turnover
of RMB129.19b.
The SZSE Component Index now rose 60 points, or 0.42% to 14,423, with an overall
turnover of RMB86.71b.
Basic Information
=================
---------------------------------
Nominal 24.500 % Chg +9.13%
High 24.700 Low 22.550
Shares Tr 2m Turnover 47.63m
10-D SMA 27.215 %H.V 98.878
20-D SMA 30.865 VWAP 23.780
50-D SMA 34.262 RSI14 35.980
---------------------------------
Status: Active buy/sell ratio is 59:41, with net buying turnover of HK$8.42m, rising a
combined 10.86% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
BRII-B (02137) 24.50 +9.13
GENSCRIPT BIO (01548) 31.20 +1.30
ASCLETIS-B (01672) 5.99 +11.96
INNOVENT BIO (01801) 42.65 +2.52
JUNSHI BIO (01877) 61.10 +3.56
WUXI BIO (02269) 91.95 +1.94
TIGERMED (03347) 95.35 +3.92
CANSINOBIO-B (06185) 176.30 +0.28
AKESO-B (09926) 29.20 +3.18
KINTOR PHARMA-B (09939) 12.20 +5.17
-----------------------------------------------
(ed)